DNA Diagnostics Market on position to touch $19 Billion by 2020, Globally : Roche Diagnostics, Bayer Diagnostic, Sysmex, Abbott laboratories, Gene-probe Inc., and Other Top Key Players Included

DNA diagnostics is a cutting edge method which is set to revolutionize the field of medical diagnostics. This technique enables medical professionals to identify various diseases, such as cancer, infectious diseases, and myogenic disorders, and to determine the appropriate treatment for the same.

DNA diagnostics Market Report is expected to garner $19 billion by 2020, registering a CAGR of 9.8% during the period 2014-2020. The potential to provide accurate diagnosis and cost effectiveness over alternative diagnostic techniques are factors which supplement the growth of the DNA diagnostics market.

Request Sample/ TOC Report @ https://www.alliedmarketresearch.com/request-sample/298

"Next generation sequencing not only reduces the cost of sequencing, but increases the throughput as well; it could thus help in bridging the gaps in traditional and personalized medications", adds the analyst. This makes it a promising investment opportunity for key players. Illumina Inc.'s new cost-effective genome machine HiSeq X Ten -the world's first DNA crunching supercomputer- is leading to a significant reduction in the price of sequencing a human genome.

AMR analysis suggests that the tremendous potential of novel DNA diagnostic technologies and the probability of them being adopted in personalized medicines has not only reduced the expenditure in diagnostic procedures but has also helped in increasing the efficiency of chronic disease identification. Furthermore, the emergence of personalized medicines and the rising number of initiatives vis--vis product development and clinical trials forkey players has laid the groundwork for DNA diagnostics technologies. Various technologies such as PCR, sequencing technology, microarrayin situ hybridization and mass spectrometry are considered in this report, with special emphasis on key market trends and their growth potential. Given its wide scope of application in almost all activities related to DNA diagnostics, the polymerase chain reaction (PCR) technology holds the largest share of DNA diagnostics market revenue.

Market analysis in terms of geography suggests that developed economies would retain their dominance in the market. This could be attributed to the early adoption of the technology due to potential reduction offered by DNA diagnostic to their high healthcare expenditure. However, developing economies, such as in Asia-Pacific, will significantly influence the DNA diagnostic market during the extended forecast period (2020-2025), largely due to potential growth in per capita healthcare expenditure and very large undiagnosed population.

Send Enquiry on this report @ https://www.alliedmarketresearch.com/purchase-enquiry/298

Several companies operating in this region are seeking novel technologies to gain traction in the competitive market. Product launch is the key strategy adopted by companies operating in this market. These companies are developing novel products for the treatment of various diseases such as infectious diseases, cancer, prenatal diagnosis, pre-implantation diagnostics and myogenic disorder. Additionally, these companies are also adopting collaboration and acquisition to retain their respective positions and to gain traction in the market. Key companies profiled in the report are Bayer Diagnostic, Sysmex, Roche Diagnostics, Abbott laboratories, Cephide, Gene-probe Inc., Illumina, Inc., Thermo Fisher Scientific, Bio-Rad Laboratories, Johnson and Johnson, and Novartis.

KEY BENEFITS

• An in-depth analysis of various regions would provide a clear understanding of current and future trends so that companies can make region specific plans
• The report studies the application of next generation sequencing technology and biotechnology and their impact on the DNA diagnostics market
• A comprehensive analysis of the factors that drive and restrict the growth of the DNA diagnostics market is provided
• Key regulatory guidelines in various regions which impact the DNA diagnostics market are critically examined
• A quantitative analysis of the current market and estimations through 2013-2020 are provided to showcase the financial caliber of the DNA diagnostics market
• Detailed analysis of the Asia-pacific region provides insights that would enable companies to plan their business move strategically
• Value chain analysis in the report gives a clear understanding of the roles of the stakeholders involved in the supply chain of the DNA diagnostics market

MARKET SEGMENTATION:

The DNA diagnostics market is segmented based on product type, technology, application, end users and geography

MARKET BY PRODUCT TYPE

• Instruments
• Reagents
• Service & Software

MARKET BY TECHNOLOGY

• PCR
• Microarray
• In-situ Hybridization
• Sequencing Technology
• Mass Spectrometry
• Others

For More Info Visit @ https://www.alliedmarketresearch.com/press-release/DNA-diagnostics-market-is-expected-to-reach-19-billion-by-2020-allied-market-research.html

About us

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.